 |
|
|
|
 |
|
|
|
 Contact |  Print version |  PDF version |  Recommend product |  RSS-Feed
Next generation sequencing extends the services of AGOWA genomics
AGOWA genomics adds the Roche GS FLX system to its sequencing portfolio
|
AGOWA genomics, part of the international science-based company LGC, has added a Genome Sequencer FLX System from Roche to its technology portfolio. The acquisition of the Roche GS FLX enables AGOWA genomics to meet the growing market demands for higher capacity and higher throughput.
AGOWA genomics’ customers can now take advantage of the company’s increased sequencing capacity and the expanded range of applications and services:
Features of the new next generation sequencing service are:
-
De novo sequencing of prokaryotic and small eukaryotic genomes
- Analysis of metagenomes, transcriptomes / normalised cDNA, methylation patterns, pools of tagged fosmids and BACs
- Targeted re-sequencing (exon / amplicon sequencing)
- Finishing of de novo sequencing in combination with Sanger sequencing
|
Furthermore AGOWA genomics is one of the first sites to apply the novel GS FLX TITANIUM series of reagents that Roche will launch in autumn 2008. The benefit of the TITANIUM series is the significantly longer read length of over 400 bases, with approximately 1.25 million reads per picotiter plate resulting in 500 million bases.
|
Additional information
AGOWA GmbH
Berlin, Germany
Company
Jobs
Products
|
|
|
|
|
|
Top
Product web page
